Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 24, 2009

Premium

Aushon Biosystems has hired Mark Schmeizl to be vice president of North American sales. Schmeizl previously was a senior sales and marketing executive at PerkinElmer, Cisbio, and Affymetrix.


David Sneider has been named chief financial officer at Nerites. He joined the Madison, Wis.-based biotech from NimbleGen. He also previously served as CFO of Third Wave Technologies.


David Cox has joined Pfizer at chief scientific officer of its target generation unit. Cox was a co-founder of Perlegen, and he served as CSO at the company since 2000. He was a genetics and pediatrics professor at Stanford University School of Medicine, and he was a co-director of the Stanford Genome Center.


Joshua LaBaer has joined the Biodesign Institute at Arizona State University to serve as director of the new Virginia G. Piper Center for Personalized Diagnostics. LaBaer was most recently director of the Harvard Institute of Proteomics.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.